Understanding microvascular inflammation in kidney transplants
Comprehensive Multiscale Characterization of the Molecular Landscape of Microvascular Inflammation in Kidney Allografts
Paris Translational Research Center for Organ Transplantation · NCT06342128
This study looks at how inflammation in small blood vessels affects kidney transplants to see if understanding it better can help improve treatment for kidney transplant patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Paris Translational Research Center for Organ Transplantation (other) |
| Locations | 3 sites (Paris and 2 other locations) |
| Trial ID | NCT06342128 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the molecular landscape of microvascular inflammation in kidney allografts, particularly in light of recent updates to the Banff classification. By employing a multimodal phenotyping approach, including histological analyses and transcriptomic profiling, the study seeks to identify the pathophysiological mechanisms associated with different phenotypes of microvascular inflammation. The findings will be compared across various clinical scenarios to enhance understanding and potentially guide targeted therapeutic strategies for kidney transplant recipients.
Who should consider this trial
Good fit: Ideal candidates for this study are adult kidney transplant recipients who have undergone at least one biopsy assessed according to the Banff 2022 classification.
Not a fit: Patients with inadequate biopsy samples or those showing signs of ischemia-reperfusion may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for kidney transplant recipients experiencing microvascular inflammation.
How similar studies have performed: While the study addresses a critical area of kidney transplant research, the specific approach of deciphering the molecular landscape of microvascular inflammation is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Adult kidney transplant recipients, with at least one kidney transplant biopsy performed and assessed according to the international Banff 2022 classification, with or without lesions of microvascular inflammation Exclusion Criteria: * Inadequate biopsy according to the Banff classification * Missing data for Banff lesion scores, donor-specific antibody status, C4d staining * Biopsies showing histological signs of ischemia-reperfusion * Combined transplantation and kidney transplantation after a non-kidney solid organ transplantation
Where this trial is running
Paris and 2 other locations
- Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris — Paris, France (RECRUITING)
- Kidney Transplant Department, Necker Hospital, Assistance Publique - Hôpitaux de Paris — Paris, France (RECRUITING)
- Bichat Hospital, Assistance Publique - Hôpitaux de Paris — Paris, France (RECRUITING)
Study contacts
- Study coordinator: Alexandre Loupy, MD PhD
- Email: alexandreloupy@inserm.fr
- Phone: +33612491082
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Kidney Rejection Transplant